Cargando…
SKLB023 hinders renal interstitial fibrosis in obstructive nephropathy by interfering TGF-β1/Smad3 signaling
Renal fibrosis is the principal process underlying the progression of chronic kidney disease to end-stage renal disease. It is a relatively uniform response involving glomerulosclerosis, tubulointerstitial fibrosis and changes in renal vasculature. A considerable number of studies have confirmed tha...
Autores principales: | Feng, Yanhuan, Xu, Jun, Guo, Fan, Huang, Rongshuang, Shi, Min, Li, Lingzhi, Ma, Liang, Fu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078199/ https://www.ncbi.nlm.nih.gov/pubmed/35539579 http://dx.doi.org/10.1039/c8ra00018b |
Ejemplares similares
-
SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway
por: Zhang, Jinhang, et al.
Publicado: (2018) -
Protective effects of SKLB023 on a mouse model of unilateral ureteral obstruction by the modulation of gut microbiota
por: Feng, Yanhuan, et al.
Publicado: (2018) -
Cryptotanshinone hinders renal fibrosis and epithelial transdifferentiation in obstructive nephropathy by inhibiting TGF-β1/Smad3/integrin β1 signal
por: Wang, Wei, et al.
Publicado: (2017) -
SKLB023 protects mice against acute liver injury by inhibiting proinflammatory cytokine production in both T cells and macrophages
por: Yu, Jia, et al.
Publicado: (2018) -
Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis
por: Li, Yanping, et al.
Publicado: (2019)